Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Kaneka discloses anti-H. pylori rifamycins

May 6, 1997

Prokinetic agents from Kyorin

May 6, 1997

Positive results from preclinical studies with darifenacin

May 5, 1997

Positive preclinical results for T-330 in animal models of gastric ulcers

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Compounds combining PAF antagonist and 5-ASA claimed by Uriach for IBD

April 29, 1997

Novopharm and Glaxo Wellcome reach agreement for ranitidine

April 28, 1997

ImmuCell's TravelGAM to enter field study in cooperation with U.S. Navy

April 24, 1997

DA-9601 shows promise for IBD

April 23, 1997

Isis Pharmaceuticals initiates phase III trials of its antisense drug for Crohn's disease

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...